Literature DB >> 21177891

High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan.

Masahiro Yamaguchi1, Yasuko Sano, Isolde C Dapat, Reiko Saito, Yasushi Suzuki, Akihiko Kumaki, Yugo Shobugawa, Clyde Dapat, Makoto Uchiyama, Hiroshi Suzuki.   

Abstract

In eight successive seasons (2001 to 2009), a total of 726 human respiratory syncytial virus (HRSV) infections from a total of 1,560 children with acute lower respiratory tract illness were identified. Molecular analysis of the attachment (G) protein gene confirmed that 52 (7.8%) children were infected more than once with any of the 3 genotypes of HRSV-A (genotypes GA5, NA1, and NA2) and/or 6 genotypes of HRSV-B (genotypes BA4, BA5, and BA7 to BA10). Repeated infections in 46 cases (82.1%) occurred in the next season, and only one case occurred in the same season (10-day interval). First infections were 33 (63.5%) HRSV-A cases and 19 (36.5%) HRSV-B cases, whereas second infections occurred in 35 (67.3%) HRSV-A cases and 17 (32.7%) HRSV-B cases. Third infections were attributed to 4 (100.0%) HRSV-A cases. Homologous subgroup reinfections were detected in 28 cases, 23 HRSV-A cases and 5 HRSV-B cases (P = 0.005), whereas homologous genotype reinfections were detected only for 5 HRSV-A cases (2GA5 and 3NA2) but not any HRSV-B case. Heterologous subgroup reinfections were detected in 28 cases, 12 cases from HRSV-A-to-HRSV-B reinfections and 16 cases from HRSV-B-to-HRSV-A reinfections. Genotypes NA1 and NA2 had higher numbers of heterologous genotype infections than did other genotypes. Our observations suggest that repeated infections occur more frequently in HRSV-A strains than in HRSV-B strains, and heterologous genotype reinfections occur more frequently than homologous genotype reinfections, especially in the case of the emerging genotypes NA1 and NA2 of HRSV-A strains that circulated in the community during our study period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177891      PMCID: PMC3067727          DOI: 10.1128/JCM.02132-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Two distinct subtypes of human respiratory syncytial virus.

Authors:  M A Mufson; C Orvell; B Rafnar; E Norrby
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

2.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

4.  An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test.

Authors:  H V Coates; D W Alling; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

5.  New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan.

Authors:  Isolde C Dapat; Yugo Shobugawa; Yasuko Sano; Reiko Saito; Asami Sasaki; Yasushi Suzuki; Akihiko Kumaki; Hassan Zaraket; Clyde Dapat; Taeko Oguma; Masahiro Yamaguchi; Hiroshi Suzuki
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

Review 6.  Molecular epidemiology of respiratory syncytial virus.

Authors:  P A Cane
Journal:  Rev Med Virol       Date:  2001 Mar-Apr       Impact factor: 6.989

7.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

8.  Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks.

Authors:  R M Hendry; A L Talis; E Godfrey; L J Anderson; B F Fernie; K McIntosh
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

9.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

10.  Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.

Authors:  W P Glezen; A Paredes; J E Allison; L H Taber; A L Frank
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

View more
  18 in total

1.  Genetic analysis and antigenic characterization of human respiratory syncytial virus group A viruses isolated in Germany 1996-2008.

Authors:  Ortwin Adams; Judith Werzmirzowsky; Hartmut Hengel
Journal:  Virus Genes       Date:  2013-06-18       Impact factor: 2.332

Review 2.  The innate immune response to RSV: Advances in our understanding of critical viral and host factors.

Authors:  Yan Sun; Carolina B López
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

3.  Molecular evolution of haemagglutinin (H) gene in measles virus.

Authors:  Hirokazu Kimura; Mika Saitoh; Miho Kobayashi; Haruyuki Ishii; Takeshi Saraya; Daisuke Kurai; Hiroyuki Tsukagoshi; Komei Shirabe; Atsuyoshi Nishina; Kunihisa Kozawa; Makoto Kuroda; Fumihiko Takeuchi; Tsuyoshi Sekizuka; Hisanori Minakami; Akihide Ryo; Makoto Takeda
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

4.  Evaluation of respiratory syncytial virus group A and B genotypes among nosocomial and community-acquired pediatric infections in Southern Brazil.

Authors:  Fernanda de-Paris; Caroline Beck; Luciana de Souza Nunes; Alice Beatriz Mombach Pinheiro Machado; Rodrigo Minuto Paiva; Denise da Silva Menezes; Márcia Rosane Pires; Rodrigo Pires dos Santos; Ricardo de Souza Kuchenbecker; Afonso Luis Barth
Journal:  Virol J       Date:  2014-02-24       Impact factor: 4.099

5.  Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014.

Authors:  Anwar Ahmed; Shakir H Haider; Shama Parveen; Mohammed Arshad; Hytham A Alsenaidy; Alawi Omar Baaboud; Khalid Fahad Mobaireek; Muslim Mohammed AlSaadi; Abdulrahman M Alsenaidy; Wayne Sullender
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

6.  Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya.

Authors:  Charles N Agoti; Alexander G Mwihuri; Charles J Sande; Clayton O Onyango; Graham F Medley; Patricia A Cane; D James Nokes
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

7.  Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes.

Authors:  Lieselot Houspie; Philippe Lemey; Els Keyaerts; Eva Reijmen; Valentijn Vergote; Anne Vankeerberghen; Freya Vaeyens; Hans De Beenhouwer; Marc Van Ranst
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

8.  Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups a and B in children in recent five consecutive years.

Authors:  Guanglin Cui; Runan Zhu; Yuan Qian; Jie Deng; Linqing Zhao; Yu Sun; Fang Wang
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

9.  Novel clinical features of recurrent human respiratory syncytial virus infections.

Authors:  Ikuko Yui; Motoko Fujino; Akihito Sawada; Tetsuo Nakayama
Journal:  J Med Virol       Date:  2013-10-25       Impact factor: 2.327

10.  Molecular epidemiology of human respiratory syncytial virus among children in Japan during three seasons and hospitalization risk of genotype ON1.

Authors:  Akinobu Hibino; Reiko Saito; Kiyosu Taniguchi; Hassan Zaraket; Yugo Shobugawa; Tamano Matsui; Hiroshi Suzuki
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.